A new DRUG TRIALS SNAPSHOT is now available.
OCREVUS is used for the treatment of patients with two types of multiple sclerosis (MS):
- relapsing forms of multiple sclerosis (RMS)
- primary progressive multiple sclerosis (PPMS).
In RMS patients have episodes of worsening function (relapses) followed by recovery periods. In PPMS patients have steadily worsening function from the onset of symptoms.